CHRISTOPHER SULLIVAN plan to sell securities of AVALO THERAPEUTICS, INC. under Form 144

CHRISTOPHER SULLIVAN filed Form 144 to notify SEC of plan to sell 16915 units of AVALO THERAPEUTICS, INC. securities around 2026-04-29, with aggregate market value of $217,526.90. The total outstanding units is 22788452.0. The amount planned to be sold represents 0.07% of total outstanding units; Recent transactions in past 3 months include: On 04/02/2026, sold 7980 units for $136822.69; On 04/01/2026, sold 7979 units for $133770.33;